This article was originally published in The Gray Sheet
Executive SummaryBiotronik received FDA approval on Feb. 9 of a premarket approval application supplement for its Gemnos 04 and PMS 600 Programmer with Module SWM 600, Version C00U02. "The Gray Sheet" (March 29, p. 9) incorrectly reported the model numbers of the devices.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.